logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Medical Device
Filter

Medical Device

Categories

Sectors

Locations

Exchange

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Japan’s Regulatory Agency, PMDA, Clears RepliCel Life Sciences to Proceed to Final Consultation for Tendon and Skin Cell Therapy Products

Mar 11, 2020

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Japan’s Patent Office Issues RepliCel Two New Patents for its Regenerative Medicine Technologies

Mar 10, 2020

美国疾病预防控制中心 冠状病毒测试 PerkinElmer

Healthcare Roundup – Coronavirus testing available in every state, PerkinElmer cuts views due to coronavirus outbreak

Mar 10, 2020

Life Science

亚盛医药 APG-2575

Ascentage Pharma Announces Clearances for Three Phase Ib/II Clinical Studies of APG-2575 in China and the U.S., Beginning Simultaneous Clinical Development in Three Hematologic Malignancy Indications

Mar 9, 2020

Life Science

Production of Dermal Injectors Delayed by China Work Stoppage Effecting Critical Component

Mar 9, 2020

Life Science

西奈山 和铂医药 癌症 新冠病毒

Mount Sinai and Harbour BioMed Collaborate to Advance Novel Biotherapies for the Treatment of Cancer and Coronavirus COVID-19

Mar 6, 2020

Life Science

新冠病毒 生物制药

Coronavirus Stimulates Biopharma and Academia Research Activities and Collaborations

Mar 5, 2020

Life Science

上海挚盟医药 HBV

Shanghai Zhimeng Starts US Phase I Trial of Novel HBV Treatment

Mar 5, 2020

Life Science

罗氏 Actemra 冠状病毒

China approves use of Roche arthritis drug for coronavirus patients

Mar 4, 2020

Life Science

英特尔 联想 华大基因

Intel, Lenovo Help BGI Genomics Speed Up Coronavirus Genome Analysis

Mar 4, 2020

Life Science

美联储 国家灾难计划 冠状病毒 礼来

Healthcare Roundup – Feds mull use of national disaster program for coronavirus care, Coronavirus outbreak to not affect supply of medicines

Mar 3, 2020

Life Science

美国Abpro在亚洲上市免疫肿瘤学和眼科药物

Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets

Mar 3, 2020

Life Science

Generex 北京中华 冠状病毒 疫苗

Generex Signs Contract with Chinese Partners Beijing Zhonghua Investment Fund Management Co., LTD and Sinotek-Advocates International Industry Development (Shenzhen) Co., Ltd. to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccine Technology

Mar 2, 2020

Life Science

医疗保健精选——冠状病毒推高股价,赛诺菲为慈善调查案支付1,185万美元和解费

Healthcare Roundup – Another big session in store for coronavirus names,Sanofi to pay $11.85M to resolve drug charity probe

Feb 28, 2020

Life Science

Berkeley Lights 新冠肺炎

Researchers Worldwide Are Using Berkeley Lights’ Beacon Platform To Combat COVID-19

Feb 28, 2020

Life Science

准确率超高! 平安新冠肺炎智能阅片系统助疫区医生更高效

Ping An Launches COVID-19 Smart Image-Reading System to Help Control the Epidemic

Feb 28, 2020

Life Science

吉利德 瑞德昔韦 谷歌 1Life

Healthcare Roundup – Clinical trial of Gilead’s remdesivir in Covid-19 starts, Google-backed 1Life draws analyst praise

Feb 25, 2020

Life Science

Healthcare Roundup – Gilead gains 4.8% as WHO sees potential in its antiviral drug, Moderna ships first batch of coronavirus vaccine for human trials

Feb 24, 2020

Life Science

  • ‹‹ Previous
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada